QLGN icon

Qualigen Therapeutics
QLGN

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $2.86M invested in Qualigen Therapeutics in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding in top 10

Funds holding in top 10: →

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$150K

Top Sellers

1
-$380K
2
-$333K
3
-$100K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$80K
5
TMC
Trellus Management Company
Florida
-$46K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.14M
2
$568K
3
$500K
4
$232K
5
$150K
6
$85K
7
$78K
8
$42K
9
$17K
10
$16K
11
$15K
12
$14K
13
$1K
14
–
15
–
16
–